Cleared Traditional

K922340 - ENCORE SS-B

K922340 is an FDA 510(k) clearance for ENCORE SS-B, manufactured by Clark Laboratories, Inc.. The device is a Class 2 Immunology device with product code LLL cleared through the Traditional 510(k) pathway after a 150-day FDA review.

K922340 · Clark Laboratories, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1992
Decision
150d
Days
Class 2
Risk

K922340 is an FDA 510(k) clearance for the ENCORE SS-B. Classified as Extractable Antinuclear Antibody, Antigen And Control (product code LLL), Class II - Special Controls.

Submitted by Clark Laboratories, Inc. (Blairstown, US). The FDA issued a Cleared decision on October 16, 1992 after a review of 150 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Clark Laboratories, Inc. devices

FDA 510(k) Submission Details - K922340

510(k) Number K922340 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 19, 1992
Decision Date October 16, 1992
Days to Decision 150 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
45d slower than avg
Panel avg: 105d · This submission: 150d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLL Device Classification - Class 2, Special Controls

Product Code LLL Extractable Antinuclear Antibody, Antigen And Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - LLL Extractable Antinuclear Antibody, Antigen And Control

All 138
Devices cleared under the same product code (LLL) and FDA review panel - the closest regulatory comparables to K922340.
ENA SCREENING CIE KIT FOR DIAGNOSTIC USE
K924262 · The Binding Site, Ltd. · Dec 1992
QUANTA LITE(TM) SCL-70 ELISA
K924898 · Inova Diagnostics, Inc. · Dec 1992
IMMUNODOT(R) ENA/DNA AUTOIMMUNITY SCREENING PANEL
K924843 · General Biometrics, Inc. · Dec 1992
QUANTA LITE ENA ELISA
K922829 · Inova Diagnostics, Inc. · Sep 1992
QUANTA LITE SS-A ELISA
K922830 · Inova Diagnostics, Inc. · Sep 1992
QUANTA LITE SM ELISA
K922831 · Inova Diagnostics, Inc. · Sep 1992